Literature DB >> 20307571

Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.

Joseph N Jarvis, Graeme Meintjes, Thomas S Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20307571      PMCID： PMC2879388          DOI： 10.1016/j.jinf.2010.03.007

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  11 in total

Review 1.  Immune restoration disease after antiretroviral therapy.

Authors:  Martyn A French; Patricia Price; Shelley F Stone
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

2.  Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.

Authors:  Olivier Lortholary; Gwendoline Poizat; Valérie Zeller; Ségolène Neuville; André Boibieux; Muriel Alvarez; Pierre Dellamonica; Françoise Botterel; Françoise Dromer; Geneviève Chêne
Journal:  AIDS       Date:  2006-11-14       Impact factor: 4.177

Review 3.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Xavier Anglaret; Landon Myer; Robin Wood
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

4.  The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana.

Authors:  Gregory P Bisson; Rudo Nthobatsong; Rameshwari Thakur; Gloria Lesetedi; Kavita Vinekar; Pablo Tebas; John E Bennett; Stephen Gluckman; Tendani Gaolathe; Rob R MacGregor
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

5.  Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Authors:  Joseph N Jarvis; Stephen D Lawn; Monica Vogt; Nonzwakazi Bangani; Robin Wood; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

6.  Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis.

Authors:  Joseph N Jarvis; Graeme Meintjes; Zomzi Williams; Kevin Rebe; Thomas S Harrison
Journal:  S Afr Med J       Date:  2010-06

7.  Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.

Authors:  Tihana Bicanic; Graeme Meintjes; Robin Wood; Madeleine Hayes; Kevin Rebe; Linda-Gail Bekker; Thomas Harrison
Journal:  Clin Infect Dis       Date:  2007-05-25       Impact factor: 9.079

8.  Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases.

Authors:  Joseph N Jarvis; Graeme Meintjes; Anthony Williams; Yolande Brown; Tom Crede; Thomas S Harrison
Journal:  BMC Infect Dis       Date:  2010-03-15       Impact factor: 3.090

9.  High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.

Authors:  Joseph N Jarvis; Andrew Boulle; Angela Loyse; Tihana Bicanic; Kevin Rebe; Anthony Williams; Thomas S Harrison; Graeme Meintjes
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

10.  Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.

Authors:  Tihana Bicanic; Conrad Muzoora; Annemarie E Brouwer; Graeme Meintjes; Nicky Longley; Kabanda Taseera; Kevin Rebe; Angela Loyse; Joseph Jarvis; Linda-Gail Bekker; Robin Wood; Direk Limmathurotsakul; Wirongrong Chierakul; Kasia Stepniewska; Nicholas J White; Shabbar Jaffar; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079
View more
  23 in total

1.  Cryptococcal Meningitis: Diagnosis and Management Update.

Authors:  Mahsa Abassi; David R Boulware; Joshua Rhein
Journal:  Curr Trop Med Rep       Date:  2015-06-01

2.  Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

Authors:  Nelesh P Govender; Jaymati Patel; Marelize van Wyk; Tom M Chiller; Shawn R Lockhart
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

Review 3.  Treatment principles for Candida and Cryptococcus.

Authors:  Laura C Whitney; Tihana Bicanic
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

4.  Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.

Authors:  Joseph N Jarvis; Graeme Meintjes; Kevin Rebe; Gertrude Ntombomzi Williams; Tihana Bicanic; Anthony Williams; Charlotte Schutz; Linda-Gail Bekker; Robin Wood; Thomas S Harrison
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

5.  Screening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria.

Authors:  Favour Osazuwa; John Osilume Dirisu; Patrick Evbaguehita Okuonghae; Ose Ugbebor
Journal:  Oman Med J       Date:  2012-05

6.  Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Ann Percival; Sean Bauman; Joy Pelfrey; Graeme Meintjes; G Ntombomzi Williams; Nicky Longley; Thomas S Harrison; Thomas R Kozel
Journal:  Clin Infect Dis       Date:  2011-09-21       Impact factor: 9.079

7.  Global HIV neurology: a comprehensive review.

Authors:  Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

Review 8.  Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Authors:  Peter R Williamson; Joseph N Jarvis; Anil A Panackal; Matthew C Fisher; Síle F Molloy; Angela Loyse; Thomas S Harrison
Journal:  Nat Rev Neurol       Date:  2016-11-25       Impact factor: 42.937

9.  Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.

Authors:  Jennie McKenney; Sean Bauman; Brandon Neary; Roger Detels; Audrey French; Joseph Margolick; Brian Doherty; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2014-11-24       Impact factor: 9.079

Review 10.  Asymptomatic cryptococcemia in resource-limited settings.

Authors:  Ana-Claire Meyer; Mark Jacobson
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.